Group One Trading’s Capricor Therapeutics CAPR Stock Holding History
Bought
Maintained
Sold
Other funds holding CAPR
TCM
SCM
RCM
BCM
Group One Trading's CAPR Position: Q2 2026 in Review
Group One Trading increased its Capricor Therapeutics (CAPR) stake by 114% in Q2 2026, buying an estimated $4.41M and bringing the position to 272,609 shares worth $6.56M. The position accounts for 0.01% of the portfolio, ranked #1211.
Group One Trading first reported a position in CAPR in Q1 2021 and has held it in 18 quarters since. 170 funds tracked by Wall St. Rank hold CAPR as of Q2 2026.
- Group One Trading held 272,609 shares of Capricor Therapeutics worth $6.56M as of Q2 2026.
- Group One Trading bought 145,471 Capricor Therapeutics shares in Q2 2026, an estimated $4.41M.
- Capricor Therapeutics made up 0.01% of Group One Trading's portfolio in Q2 2026, its #1211 holding.
- Group One Trading first reported a position in Capricor Therapeutics in Q1 2021 and has held it in 18 quarters since.
- 170 funds tracked by Wall St. Rank held Capricor Therapeutics as of Q2 2026.
Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.